Exploring the Future of Aesthetics: A Conversation with Claire Reach, Founder of MapHealth In a recent interview with Claire Reach, Founder of MapHealth, we delved into the evolving landscape of aesthetics and the growing trend towards holistic wellness within the industry.
34% of UK aesthetic practices now offer at least one medical wellness treatment alongside their core aesthetic services, a finding from the Rare. report Beyond Injectables: How the Aesthetics Market is embracing Wellness and Longevity. The figure represents a measurable shift in how aesthetic clinics define their commercial offer. To understand what that shift looks like from the operator side, we spoke to Claire Reach, founder of MapHealth.
On the significance of the 34% number
Claire Reach: The 34% figure reflects a pivotal shift in how practitioners approach patient care. It signals a departure from traditional aesthetics towards a more comprehensive approach centred around overall health and well-being. Patients are increasingly seeking more than superficial treatments. They want holistic solutions that address both their aesthetic concerns and their broader health goals.
On declining interest in dermal fillers and botulinum toxin
Claire Reach: There is a profound cultural shift towards prioritising wellness and longevity over traditional medical aesthetics. Patients are drawn to treatments that offer long-term benefits beyond cosmetic enhancement. The trend underscores the growing awareness, among both practitioners and patients, that medical aesthetics and overall health are connected rather than separate categories.
On the operational challenge of medical wellness
Claire Reach: The primary challenge is balancing profitability with value-based care. There is a clear and growing demand for medical wellness treatments, but clinics need to navigate the financial reality of integrating them into existing practice models without compromising on patient outcomes. It requires a strategic approach. The clinics that get this right design their wellness pathway with clear pricing, appropriate clinician time, and a long-term patient plan that justifies the investment.
On where the market is going
Claire Reach: The aesthetics market is heading for a remarkable transformation. With the increasing emphasis on holistic wellness and longevity, we will see a continued shift towards personalised care. The evolution will combine medical aesthetics and preventive medicine, with practitioners playing a more proactive role in supporting patients' overall health journeys. As innovation in technology and treatment continues to emerge, aesthetics and medical wellness will become increasingly indistinguishable.
On the surprising findings in the report
Claire Reach: The 51% of clinics offering functional medicine assessments is the figure that stood out for me. That is a substantial proportion of the market that has invested in the assessment infrastructure required to do this credibly. The other side of the data is that nutritional counselling sits at 7%, which represents a significant whitespace. Nutrition is one of the highest-leverage health interventions a clinic can offer, and the fact that it is so under-represented suggests there is a real opportunity for clinics that move into it now.
What this means for the market
The conversation with Claire Reach reinforces what the data shows: the aesthetics industry is professionalising into a longer, deeper patient relationship that draws on functional medicine, supplementation, and wellness assessment alongside traditional aesthetic services. The clinics that adapt their commercial model to that shift will compound. The clinics that do not will see their patient base migrate to providers that have. The full report Beyond Injectables: How the Aesthetics Market is embracing Wellness and Longevity is available to download from the Rare. site.
